C11. 9 - Malignant neoplasm of nasopharynx, unspecified. ICD-10-CM.
Nasopharyngeal cancer is a type of head and neck cancer. It starts in the nasopharynx, the upper part of the throat behind the nose and near the base of skull. Cancer starts when cells begin to grow out of control.
Abstract. Nasopharyngeal carcinoma is an unusual neoplasm among squamous cell carcinomas of the head and neck. The tumor is rare in most parts of the world but is strikingly common in several Asian subpopulations, notably Chinese in Hong Kong and Guangdong Province.
According to the World Health Organization (WHO), NPC is classified into 3 subtypes: Keratinizing squamous cell carcinoma (WHO type 1) Nonkeratinizing squamous cell carcinoma (WHO type 2) Undifferentiated or poorly differentiated carcinoma, including lymphoepithelioma and anaplastic variants (WHO type 3)
Malignant neoplasm of nasopharynx, unspecified C11. 9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C11. 9 became effective on October 1, 2021.
Cancer that spreads to other areas of the body. Nasopharyngeal carcinoma frequently spreads (metastasizes) beyond the nasopharynx. Most people with nasopharyngeal carcinoma have regional metastases. That means cancer cells from the initial tumor have migrated to nearby areas, such as lymph nodes in the neck.
Undifferentiated carcinoma of the nasopharynx (UCNT) is a particular head and neck epidermoid lineage tumor related to the Epstein Barr Virus (EBV). It has geographically selective endemic epidemiologic features, without relation to external carcinogens.
Stage 3 nasopharyngeal cancer means one of the following: The cancer has spread to nearby bones and air cavities (sinuses). It might also have spread to lymph nodes on one or both sides of the neck, or behind the throat, but not anywhere else. The affected lymph nodes are not more than 6 cm across.
Definition of nasopharyngeal : of, relating to, or affecting the nose and pharynx or the nasopharynx.
Causes of nasopharyngeal cancer having a diet very high in salt-cured meats and fish. coming into contact with the Epstein-Barr virus (EBV), a common virus that causes glandular fever. having a job where you regularly come into contact with hardwood dust or a chemical called formaldehyde.
The most common type of sinonasal cancer is squamous cell carcinoma, in which cancer develops in the cells of the mucosa, the membrane that lines the nasal cavity and sinuses.
"Carcinoma in situ" stays in the cells where it started. Not all cancers are carcinoma. Other types of cancer that aren't carcinomas invade the body in different ways.
If the cancer is located only in the nasopharynx, the 5-year survival rate is 85%. If the cancer has spread to nearby tissues or organs and/or regional lymph nodes, the 5-year survival rate is 71%. If there is distant spread to other parts of the body, the 5-year survival rate is 49%.
Symptoms of nasopharyngeal cancera lump in the neck that doesn't go away after 3 weeks.hearing loss (usually only in 1 ear)tinnitus (hearing sounds that come from inside the body rather than from an outside source)a blocked or stuffy nose (usually only blocked on 1 side)nosebleeds.headaches.double vision.More items...
Many cancers of the nasopharynx can be cured, especially if they are found early. Descriptions of the common types of treatments used for NPC are listed below. Your care plan may also include treatment for symptoms and side effects, an important part of cancer care.
The main function of your nasopharynx is to connect your nasal passages to the rest of your respiratory system. This allows air to get from your nose to your lungs. Your nasopharynx also helps: Control pressure between your nasopharynx and middle ear.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...
For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned. Malignant neoplasm of ectopic tissue. Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, ...
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion '), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous such as tumors in different quadrants of the same breast, codes for each site should be assigned.
When a primary malignancy has been previously excised or eradicated from its site and there is no further treatment directed to that site and there is no evidence of any existing primary malignancy at that site, a code from category Z85, Personal history of malignant neoplasm, should be used to indicate the former site of the malignancy. Any mention of extension, invasion, or metastasis to another site is coded as a secondary malignant neoplasm to that site. The secondary site may be the principal or first-listed with the Z85 code used as a secondary code.
Chapter 2 of the ICD-10-CM contains the codes for most benign and all malignant neoplasms. Certain benign neoplasms , such as prostatic adenomas, may be found in the specific body system chapters. To properly code a neoplasm, it is necessary to determine from the record if the neoplasm is benign, in-situ, malignant, or of uncertain histologic behavior. If malignant, any secondary ( metastatic) sites should also be determined.
Code C80.0, Disseminated malignant neoplasm, unspecified, is for use only in those cases where the patient has advanced metastatic disease and no known primary or secondary sites are specified. It should not be used in place of assigning codes for the primary site and all known secondary sites.
When a pregnant woman has a malignant neoplasm, a code from subcategory O9A.1 -, malignant neoplasm complicating pregnancy, childbirth, and the puerperium, should be sequenced first, followed by the appropriate code from Chapter 2 to indicate the type of neoplasm. Encounter for complication associated with a neoplasm.
There are also codes Z85.6, Personal history of leukemia, and Z85.79, Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues. If the documentation is unclear as to whether the leukemia has achieved remission, the provider should be queried.
Code C80.1, Malignant ( primary) neoplasm, unspecified, equates to Cancer, unspecified. This code should only be used when no determination can be made as to the primary site of a malignancy. This code should rarely be used in the inpatient setting.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
Malignant neoplasm of esophagus. Approximate Synonyms. Adenocarcinoma of esophagus. Cancer of the esophagus. Cancer of the esophagus, adenocarcinoma. Cancer of the esophagus, squamous cell. Esophageal cancer metastatic to unspecified site. Metastasis from malignant tumor of esophagus.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...
Use a malignant neoplasm code if the patient has evidence of the disease, primary or secondary, or if the patient is still receiving treatment for the disease. If neither of those is true, then report personal history of malignant neoplasm.
When a primary malignancy has been previously excised or eradicated from its site and there is no further treatment directed to that site and there is no evidence of any existing primary malignancy, a code from category Z85, Personal history of malignant neoplasm, should be used to indicate the former site of the malignancy .
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
tobacco use ( Z72.0) Malignant neoplasm of nasopharynx. Approximate Synonyms. Cancer of the nasopharynx. Cancer of the nasopharynx, adenocarcinoma. Cancer of the nasopharynx, adenoid cystic. Cancer of the nasopharynx, squamous cell. Cancer of the nasopharynx, undifferentiated. Primary adenocarcinoma of nasopharynx.